Your Daily Financial Update
Opening Recap
Market Pulse: Tech slippage drags major benchmarks lower despite pockets of strength in industrials and financials.
Key Movers: SpaceX faces a potential short squeeze as detailed in ‘Elon Musk Warns Short Sellers as $25 Billion Bet Builds Against SpaceX Ahead of Earnings' and retina-care company Outlook Therapeutics gets a boost with ‘Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD'.
Macro & Politics: A leaner healthcare proposal from the Trump administration and fresh U.S. scrutiny on Chinese AI models inject policy risk into the healthcare and tech sectors.
What’s Next: We'll be tracking Fed commentary and inflation data before the bell.
Market Commentary
What everyone’s missing is how quickly the AI valuation bubble can deflate if regulators clamp down. TheStreet’s ‘Wall Street's AI trade faces its biggest valuation test' barely scratched the surface of the looming policy hammer on trading desks ready to chase these multiples. Investors are fixated on growth narratives, but a single rule change can snuff out that upside overnight, and that’s a damn real risk.
There’s a fascinating link between the recent FDA win for retina-care in ‘Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD' and the emergence of AI platforms looking to replace physicians in ‘Here Are 3 AI Companies Betting They Can Replace Doctors'. While one signals old-school biotech catalysts, the other highlights a stealth tech invasion into healthcare—two forces that could reshape which stocks lead the sector.
When the market opens, don’t sit on your hands. Consider trimming exposure to overheated AI names and rotate into biotech plays ahead of the next FDA round. Keep your stops tight and let the data drive your moves.
📈 Breaking Financial News
Rexford Industrial Realty (REXR) Stock May Be Above Fair Value Despite Q2 Earnings Beat
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
Rexford Industrial Realty stock has delivered a decline of 25.3% over the past five years, yet at around US$39 per shar…
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically for the Eye Following Years of Rigorous Clinical and Regulatory Evaluation
Intel Stock Falls 4.18% Friday Despite Strong Earnings Beat, as July's Sharp Rally Continues to Cool
Intel's shares fell despite a strong earnings report and increased capital spending plans, as investors took profits following a significant rally. The company's AI-driven growth and future outlook remain positive.
American Express Sinks 6% After Q2 Earnings Beat as Visa, Mastercard Hold Steady
American Express just posted a clear earnings beat, yet its stock is cratering while Visa and Mastercard barely flinch. The divergence points to a specific t…
Thermo Fisher Scientific Stock Surges 8.71% After Strong Q2 Earnings Beat and Raised Full-Year Guidance
Thermo Fisher Scientific's shares surged after reporting strong Q2 results, surpassing expectations and raising full-year guidance, indicating a recovery in the life sciences sector.
Wall Street's Secret Crypto Accumulation Exposed
This protocol is fueling billions in transactions while most investors chase headlines… creating what could be the most asymmetric opportunity of 2025! Revealed: Get the name of Wall Street's favorite crypto for just $3 before it potentially skyrockets!
🔍 Market Analysis & Insights
Verizon Earnings Beat, Revenue Light Amid Lower Phone Upgrades
Verizon topped Q2 earnings estimates and added more “postpaid” phone subscribers than expected. But revenue fell short.
The post Verizon Earnings Beat, Revenue Light Amid Lower Phone Upgrades appeared first on Investor's Business Daily.
Elon Musk Warns Short Sellers as $25 Billion Bet Builds Against SpaceX Ahead of Earnings
Space Exploration Technologies Corp (NASDAQ:SPCX) had the largest IPO in history in June, opening at $135 per share and momentarily reaching a $2.1 trillion…
The Trump administration’s best healthcare idea isn’t the one getting attention
By David HogbergAs always, the secret sauce isn’t more government intervention, but less.
Intel Beat Earnings by $1.7 Billion and Fell 11% as Cramer Turned Bullish
Intel beat forecasts by $1.7B and still lost 11%. Oil, rates, and chip selling explain it better. What has Jim Cramer got to do with it?
Wall Street's AI trade faces its biggest valuation test
Alphabet just reported the strongest quarter in Google Cloud's history. Revenue came in at $119.8 billion, up 24% year over year. Cloud grew 82% to $24.8 bil…
Wall St Legend: AGI Arrives Q1 2026. The Power Grab Started Months Ago.
While retail buys Nvidia at all-time highs, institutions position into something else. Why? AI needs POWER. Louis Navellier, who spent 46 yrs Wall St. and called Nvidia at $1, reveals that his grading system shows where the money is REALLY flowing. Companies you've never heard of. Stocks the media never covers. Before Stage 3 begins… Click here for the full story.
💰 Investment Opportunities
AMD Has an Agentic AI Advantage Over Nvidia That Keeps Me Buying Again and Again
Agentic AI rewires what an AI server actually needs, and most investors are still thinking about this race the wrong way. The company that quietly controls t…
AMD takes on Nvidia, US takes on Chinese AI models and AI spending still spooks investors
Maybe Nvidia ultimately won’t win the entire AI enchilada, even as it reminded everyone this week that it offers everything you need to build AI factories. This week, Advanced Micro Devices also announced a raft of new graphics processing units, central proce…
SYF vs. ALLY vs. COF: Which Consumer Finance Stock Is the Best Buy After Earnings?
Consumer finance stocks face a mixed environment. While consumer spending remains healthy despite higher energy prices due to inflation and growth concerns a…
Jim Cramer Says Kimberly-Clark’s Acquisition of Kenvue Creates a High-Margin Powerhouse
On Tuesday’s episode of CNBC’s Mad Money, Jim Cramer highlighted Kimberly-Clark Corporation (NYSE:KMB) as a defensive holding for investors looking to lock i…
Here Are 3 AI Companies Betting They Can Replace Doctors
Three AI startups—Doctronic, Certuma and Ada Health—are racing to replace physicians. A physician describes their approach, Here's the data, funding and regulatory hurdles.
Alert: The DeFi Token Set to Explode as Markets Recover
This isn't speculation – this platform's role is so essential to crypto's financial system that its current price defies all logic. Just Released: The DeFi token set for massive gains as markets heat up – only $3!